Trials / Not Yet Recruiting
Not Yet RecruitingNCT06312514
Lafiya HIV-status Neutral Study - Protocol
Status-neutral Community-based Multilevel Intervention to Address Intersectional Stigma and Discrimination, and Increase HIV Testing, PrEP, and ART Uptake Among YGBMSM in Ghanaian Slums: A Clustered Randomized Control Trial Protocol
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 880 (estimated)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- Male
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to adapt and evaluate the feasibility of "Lafiya," which means "Wellness" in Hausa, a multilevel intersectional stigma \& discrimination (ISD) and HIV testing intervention, to a status-neutral intervention to increase HIV testing, PrEP, and ART Uptake (HPART) among young gay, bisexual, and other men who have sex with men in Ghanaian slums. Specific objectives include, Assessing intersectional stigma and options for HPART implementation, Adapting Lafiya to a status-neutral intervention to address intersectional stigma and increase HPART uptake among YGBMSM, Test acceptance, feasibility, appropriateness, and preliminary efficacy of Lafiya to address intersectional stigma and increase HIVST uptake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | LAFIYA | The Lafiya intervention is a comprehensive program designed to address the intersectional stigma and discrimination challenges faced by marginalized communities, particularly among Gay, Bisexual, and other Men who have Sex with Men (GBMSM). It aims to enhance HIV prevention, care, and treatment outcomes, with a focus on increasing HIV self-testing (HIVST) uptake among these key populations in Ghanaian urban slum settings. |
Timeline
- Start date
- 2025-04-20
- Primary completion
- 2028-08-29
- Completion
- 2028-08-29
- First posted
- 2024-03-15
- Last updated
- 2025-02-06
Locations
1 site across 1 country: Ghana
Source: ClinicalTrials.gov record NCT06312514. Inclusion in this directory is not an endorsement.